PRP

About Propanc Biopharma

Propanc Biopharma's mission is to develop unique, effective medicines for chronic diseases like cancer with lasting benefits and minimal side effects. Its core achievement is the development of PRP, a proenzyme combination therapy that has completed a Phase 1/2 trial and is positioned as a potential differentiation therapy targeting cancer stem cells. The company's strategy involves advancing PRP through clinical development for solid tumors while expanding its intellectual property and research collaborations, particularly in Spain, to explore new formulations and indications.

About Propanc Biopharma

Propanc Biopharma's mission is to develop unique, effective medicines for chronic diseases like cancer with lasting benefits and minimal side effects. Its core achievement is the development of PRP, a proenzyme combination therapy that has completed a Phase 1/2 trial and is positioned as a potential differentiation therapy targeting cancer stem cells. The company's strategy involves advancing PRP through clinical development for solid tumors while expanding its intellectual property and research collaborations, particularly in Spain, to explore new formulations and indications.

Therapeutic Areas